$624M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | DNTH Dianthus Therapeutics Inc | 2.1M | +0.0% | $205M | 32.8% |
| 2 | CGON Cg Oncology Inc | 1.4M | +8.5% | $99M | 15.9% |
| 3 | ORKA Oruka Therapeutics Inc | 760,424 | +0.0% | $72M | 11.6% |
| 4 | JBIO Jade Biosciences Inc | 1.7M | +21.4% | $38M | 6.1% |
| 5 | ELVN Enliven Therapeutics Inc | 550,000 | +37.5% | $28M | 4.5% |
| 6 | CATX Perspective Therapeutics Inc | 6.3M | +4.1% | $21M | 3.4% |
| 7 | AKTS Aktis Oncology Inc | 484,200 | +3.3% | $16M | 2.5% |
| 8 | PVLA Palvella Therapeutics Inc Ne | 70,000 | +0.0% | $11M | 1.7% |
| 9 | MOBI Mobia Med Inc | 798,282 | — | $11M | 1.7% |
| 10 | RGEN Repligen Corp | 77,800 | +0.0% | $11M | 1.7% |
| 11 | IMUX Immunic Inc | 669,941 | — | $10M | 1.6% |
| 12 | SENS Senseonics Hldgs Inc | 1.6M | — | $9M | 1.5% |
| 13 | KPTIQ Karyopharm Therapeutics Inc | 924,487 | +99.4% | $9M | 1.4% |
| 14 | TEVA PHARMACEUTICAL INDS LTD Teva Pharmaceutical Inds Ltd | 200,000 | −55.6% | $7M | 1.1% |
| 15 | DXCM Dexcom Inc | 100,000 | +11.1% | $7M | 1.1% |
| 16 | TEM Tempus Ai Inc | 105,000 | +320.0% | $6M | 1.0% |
| 17 | MDT Medtronic Plc | 70,000 | −30.0% | $5M | 0.9% |
| 18 | VIR Vir Biotechnology Inc | 519,300 | −45.3% | $5M | 0.8% |
| 19 | GPCR Structure Therapeutics Inc | 98,000 | +226.7% | $5M | 0.8% |
| 20 | EHC Encompass Health Corp | 42,000 | +0.0% | $4M | 0.7% |
| 21 | TENX Tenax Therapeutics Inc | 265,934 | +23.2% | $4M | 0.6% |
| 22 | NVCT Nuvectis Pharma Inc | 200,000 | — | $4M | 0.6% |
| 23 | PODD Insulet Corp | 24,000 | — | $4M | 0.6% |
| 24 | BSX Boston Scientific Corp | 80,000 | +33.3% | $3M | 0.5% |
| 25 | MSLE Satellos Bioscience Inc | 387,769 | +0.0% | $3M | 0.5% |
| 26 | ALMR Alamar Biosciences Inc | 110,000 | — | $3M | 0.5% |
| 27 | CNTX Context Therapeutics Inc | 5.0M | +0.0% | $3M | 0.4% |
| 28 | GILD Gilead Sciences Inc | 20,000 | +0.0% | $3M | 0.4% |
| 29 | CHARLES RIV LABS INTL INC Charles Riv Labs Intl Inc | 10,000 | — | $2M | 0.4% |
| 30 | PHAT Phathom Pharmaceuticals Inc | 200,000 | −19.8% | $2M | 0.3% |
| 31 | AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc | 60,000 | — | $2M | 0.3% |
| 32 | KLRA Kailera Therapeutics Inc | 80,000 | — | $2M | 0.3% |
| 33 | GMAB Genmab A/S | 50,000 | +0.0% | $1M | 0.2% |
| 34 | NTLA Intellia Therapeutics Inc | 75,000 | +0.0% | $1M | 0.2% |
| 35 | CRVS Corvus Pharmaceuticals Inc | 80,000 | −30.4% | $1M | 0.2% |
| 36 | ODD Oddity Tech Ltd | 70,000 | +0.0% | $1M | 0.2% |
| 37 | SCYX Scynexis Inc | 260,206 | — | $1M | 0.2% |
| 38 | EVMN Evommune Inc | 75,000 | — | $996,750 | 0.2% |
| 39 | ABT Abbott Laboratories | 10,000 | — | $907,400 | 0.1% |
| 40 | BBIO Bridgebio Pharma Inc | 10,000 | — | $744,800 | 0.1% |
| 41 | PTON Peloton Interactive Inc | 100,000 | −50.0% | $591,000 | 0.1% |
| 42 | LEGN Legend Biotech Corp | 15,000 | — | $433,200 | 0.1% |
| 43 | BBOT Bridgebio Oncology Therapeut | 43,853 | +0.0% | $334,160 | 0.1% |
| 44 | SVRA Savara Inc | 50,000 | — | $308,000 | 0.0% |
| 45 | TRVI Trevi Therapeutics Inc | 6,660 | +0.0% | $124,209 | 0.0% |